You are here

Article info

Article menu
Download PDFPDF
4. Bone diseases
A4.4 Zoledronate efficacy and safety in active paget’s disease- long-term follow-up and retreatment in clinical practice

Authors

  • E Vieira-Sousa 1Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Académico de Medicina de Lisboa, Portugal2Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Portugal PubMed articlesGoogle scholar articles
  • A Rodrigues 1Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Académico de Medicina de Lisboa, Portugal2Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Portugal PubMed articlesGoogle scholar articles
  • J Caetano Lopes 2Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Portugal PubMed articlesGoogle scholar articles
  • S Capela 1Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Académico de Medicina de Lisboa, Portugal PubMed articlesGoogle scholar articles
  • F Ramos 1Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Académico de Medicina de Lisboa, Portugal PubMed articlesGoogle scholar articles
  • R Figueira 1Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Académico de Medicina de Lisboa, Portugal PubMed articlesGoogle scholar articles
  • J Polido-Pereira 1Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Académico de Medicina de Lisboa, Portugal2Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Portugal PubMed articlesGoogle scholar articles
  • C Ponte 1Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Académico de Medicina de Lisboa, Portugal2Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Portugal PubMed articlesGoogle scholar articles
  • R Campanilho-Marques 1Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Académico de Medicina de Lisboa, Portugal2Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Portugal PubMed articlesGoogle scholar articles
  • R Barros 1Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Académico de Medicina de Lisboa, Portugal PubMed articlesGoogle scholar articles
  • J C Romeu 1Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Académico de Medicina de Lisboa, Portugal PubMed articlesGoogle scholar articles
  • J A Pereira da Silva 1Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, Centro Académico de Medicina de Lisboa, Portugal PubMed articlesGoogle scholar articles

Citation

Vieira-Sousa E, Rodrigues A, Caetano Lopes J, et al
A4.4 Zoledronate efficacy and safety in active paget’s disease- long-term follow-up and retreatment in clinical practice
Annals of the Rheumatic Diseases 2014;73:A57-A58.

Publication history

  • First published January 31, 2014.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions